Bringing an advanced therapy from research towards clinical use requires access to much more than laboratory space. Developers need specialised expertise, manufacturing capabilities, clinical support, regulatory guidance and other services at different stages of the development pathway. But identifying the right organisation, understanding what it can provide and knowing where to start can still be difficult.
As part of its work to make Europe’s ATMP infrastructure easier to access and navigate, PRECISEU has developed the D5.3 Multi-stakeholder Infrastructure Service Catalogue. This is the second resource in our three-part WP5 series focused on improving access to ATMP infrastructures across Europe.
Making ATMP capabilities easier to identify
The Service Catalogue is designed to help ATMP developers, including startups, SMEs and academic research groups, better understand the types of expertise and services available through specialised ATMP centres and infrastructures.
It provides a structured view of capabilities relevant across the development pathway, including areas such as:
- preclinical development;
- manufacturing and GMP-related capabilities;
- clinical development;
- regulatory support;
- business and intellectual property support.
By making these capabilities more visible and easier to understand, the catalogue can support developers in identifying organisations that may be relevant to their specific development needs.
From infrastructure to usable services
Having advanced infrastructure available is only part of the challenge. For innovators, the practical questions are often much more specific: What services does a centre actually provide? At what stage of development can it support my project? Who should I approach?
D5.3 helps address these questions by shifting the focus from infrastructure alone towards the services and expertise that developers can actually access. Together with D5.2 – Blueprint for Multi-Stakeholder ATMP Infrastructure Access, the catalogue contributes to a clearer pathway for connecting ATMP developers with suitable centres and capabilities across Europe.
Building stronger connections across Europe’s ATMP ecosystem
This work is also part of a broader PRECISEU effort to strengthen connections between ATMP infrastructures and create a more connected European community of specialised centres.
The wider WP5 work around these resources has involved representatives from organisations including CCRM Nordic, CellGENTherapies, Centre for Innovative Therapies Heidelberg, CidStem / University of Modena and Reggio Emilia, Hospital Sant Joan de Déu, IRET Foundation, Leitat Technological Center and Sahlgrenska Academy & University Hospital.
Their involvement brings practical perspectives from organisations working directly across different parts of the ATMP development and translation pathway.
Three complementary resources
The WP5 series addresses three closely connected questions:
D5.2: How can ATMP developers access specialised infrastructures?
D5.3: What services and capabilities can those infrastructures provide?
D5.4: How can ATMP centres themselves be planned, governed and connected effectively?
Together, these resources aim to make Europe’s ATMP ecosystem easier to understand, navigate and use.
For a detailed overview of the services, capabilities and infrastructure covered, you can access the full D5.3 – Multi-stakeholder Infrastructure Service Catalogue.
Next in the series: D5.4 – Regulation and Governance of the Multi-stakeholder Infrastructure / Blueprint for ATMP Centers.